What is Specimen Validity Testing Market?
Urine is the most generally utilized example for medications of misuse testing. This is essentially in light of the fact that pee is promptly accessible in huge amounts and contains high convergences of parent medications and metabolites. It is consequently, an acknowledged method of testing for example legitimacy when observing for mishandled drugs whether inside the working environment, criminal equity framework (for example drug courts) or for compliance.1 as a rule, human pee reflects drugs devoured inside the previous a few days relying upon drug use. Owing to all the benefits and ease in testing urine specimens, urine samples are extremely susceptible to tampering1, making it tempting for participants to either use adulterants or dilute their urine.
The market study is being classified by Type (Laboratory Testing and Rapid/POC Testing), by Application (Workplaces, Drug Screening Laboratories, Criminal Justice and Law Enforcement Agencies, Pain Management Centers, Drug Rehabilitation Centers and Others) and major geographies with country level break-up.
Thermo Fisher (United States), Sciteck. (United States), Alere (United States), Express Diagnostics (United States), Premier Biotech (United States), LabCorp (United States), Quest Diagnostics (United States), Alere Toxicology (United States), ACM Global Laboratories (United States), Clinical Reference Laboratory (CRL) (United States) and SureHire (Canada) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are CannAmm (Canada).
The companies are exploring the market by adopting expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Specimen Validity Testing market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Specimen Validity Testing market by Type, Application and Region.
On the basis of geography, the market of Specimen Validity Testing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Growth in the Drug Screening and strict laws mandating drug screening and government funding to control drug abuse are projected to fuel the growth
- Increase in Workplace Drug Testing
- Regulatory Approvals for Rapid Testing Products
- Alternative Drug Screening Tests
- Rise in health care infrastructure, and surge in funding from market players
Key Target AudienceNew Entrants/Investors, Analysts and Strategic Business Planners, Specimen Validity Testing Manufacturer, Dealers, Suppliers, Traders, and Distributors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry